NCM·Healthcare·$206M·#315 / 520 in Healthcare
WHWK Whitehawk Therapeutics, Inc.
37HIGH RISK
CATEGORY BREAKDOWN
GROWTH0
QUALITY60
STABILITY38
VALUATION1
GOVERNANCE70
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
-72.5%
0
> 50% strong
Gross Margin
Revenue retained after direct costs
89.4%
100
> 50% strong
Cash Runway
Months of cash at current burn rate
5 months
8
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
0.0%
100
< 25% strong
Price / Sales
Market cap relative to trailing revenue
28.8x
1
< 3x strong
Rule of 40
Growth rate plus operating margin
-1674
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
13.8%
73
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
+5.7%
66
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE WHWK WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when WHWK's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.